InvestorsHub Logo
Followers 58
Posts 2505
Boards Moderated 0
Alias Born 09/21/2009

Re: tmeier post# 5475

Sunday, 03/19/2017 1:27:17 PM

Sunday, March 19, 2017 1:27:17 PM

Post# of 8449
Agree. I do think their original statement was inadequate. They tried moving the bar without moving the bar "complete in March but submit in April". With all scrutiny right now, it should have included the new pr info because April is Q2. And below they also gave no reason. So, I find the new pr nothing more than a formality of stating it right and giving the reason for record books. We shall see. All the best



The Company’s New Drug Application for KIT-302 for the U.S. Food and Drug Administration (“FDA”) is currently being finalized, and is expected to be completed by the end of March 2017 and to be submitted to the FDA within two to three weeks thereafter.